NCT07821879
- Conditions
- Cervical Cancer Screening, Genomic Instability, High Grade Serous Ovarian Cancer, +3 more
- Locations
-
- Institut Claudius Regaud Toulouse, France
Clinical trial condition
High Grade Serous Ovarian Cancer
Explore clinical trials studying High Grade Serous Ovarian Cancer. Study availability and eligibility vary by location and protocol.
11 public trials
7 recruiting studies
High Grade Serous Ovarian Cancer trial results
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States
Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
NCT07503808
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
- Locations
-
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- START New York Long Island, LLC Lake Success, New York, United States
NCT05512208
- Conditions
- Cervical Cancer, Endometrioid Cancer, Female Urogenital Diseases, +15 more
- Locations
-
- AdventHealth Orlando, Florida, United States
- Louisiana State University Medical Center New Orleans New Orleans, Louisiana, United States
- University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
- Stephenson Cancer Center Oklahoma City, Oklahoma, United States
NCT06976892
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom
- Royal Marsden Hospital - Drug Development Unit Sutton, London, United Kingdom
- Velindre Cancer Centre Cardiff, Wales, United Kingdom
NCT06084195
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- NOUGARET Stephanie Montpellier, France
NCT06777082
- Conditions
- High Grade Serous Ovarian Cancer
- Locations
-
- IRCCS Azianda Ospedaliero-Universitaria di Bologna Bologna, BO, Italy
Not yet recruiting
Minimal Residual Disease in Solid Malignancies
NCT07268469
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +30 more
- Locations
-
Not specified
Active, not recruiting
"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT01883297
- Conditions
- Adnexal Diseases, Disease Attributes, Fallopian Tube Cancer, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT03096054
- Conditions
- Breast Cancer (Triple Negative Type), Breast Diseases, Breast Neoplasms, +44 more
- Locations
-
- Northern Ireland Cancer Centre Belfast, United Kingdom
- Western General Hospital Edinburgh, United Kingdom
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
- Northern Centre for Cancer Care Newcastle upon Tyne, United Kingdom